ArticlePeerJ2025

Optimizing muscle mass and function in advanced lung cancer patients: randomized, double-blind, placebo-controlled trial protocol using High Eicosapentaenoic acid and PROtein (HEPRO) to modulate epigenetics, reduce toxicity and improve gut microbiota.

Imanuely Borchardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.